Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000125650 | SCV000169111 | benign | not specified | 2013-03-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000125650 | SCV000305149 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV001797618 | SCV002041339 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001811345 | SCV002049969 | benign | not provided | 2022-11-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001797618 | SCV002374367 | benign | Tuberous sclerosis 2 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002490629 | SCV002799098 | likely benign | Lymphangiomyomatosis; Isolated focal cortical dysplasia type II; Tuberous sclerosis 2 | 2021-07-17 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV001797618 | SCV004016137 | benign | Tuberous sclerosis 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001811345 | SCV005297706 | benign | not provided | criteria provided, single submitter | not provided | ||
Tuberous sclerosis database |
RCV000055141 | SCV000083359 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation |